5/18
Health Sciences
A Penn team’s push to make research more inclusive
Penn’s Palliative and Advanced Illness Research (PAIR) Center is working to bring more underrepresented racial and ethnic backgrounds into their research, and to train AI models to be free from bias.
A mutation hiding in one unique patient could save others from forming a ‘second skeleton’
One patient led Penn Medicine’s Fred Kaplan to a genetic discovery surrounding the “trigger” for a debilitating skeletal condition.
Small patients, big discoveries
Penn Nursing faculty and researchers are revolutionizing pediatric care to keep pace with technology, advances in treatment, and current events.
A doctor to help patients thrive in life after cancer
Jennie Barbieri provides a holistic, collaborative approach to wellness issues for cancer survivors to help improve their quality of life, delay or prevent heart disease, and manage other long-term effects of cancer treatments.
How incentives could better treat stimulant use disorder
Researchers at Penn Medicine are working to update contingency management protocols and dissemination practices that focus on incentivizing behavior for patients.
Gene editing restores some sight in pair of children treated for blindness
CRISPR-Cas9 gene editing has been found to be safe and largely effective in addressing a form of inherited blindness in a group of patients that, for the first time, included children
Intervention in Navajo Nation boosts uptake for heart failure drugs by 53%
LDI senior fellow Lauren Eberly details her latest study on the Navajo Nation reservation in New Mexico, highlighting the increased uptake of guideline-directed heart failure therapy drugs.
The Penn doctor leading the way in heart health with TAVR innovation
Howard Herrmann, the John Winthrop Bryfogle Professor of Cardiovascular Diseases in the Perelman School of Medicine and Health System director for Interventional Cardiology, is a lead researcher in the TAVR field.
New grant supports ongoing partnership between Penn Nursing and city of Philadelphia
The multiyear, multimillion dollar grant to The Philadelphia Community Engagement Alliance will focus on chronic disease self-management among Philadelphia residents.
Organ transplant drug may slow Alzheimer’s disease progression in individuals with seizures
A new study from a team at Penn Medicine finds that inhibiting neuron excitability slows the cognitive effects of Alzheimer’s disease.
In the News
What’s going on with tranq?
Jeanmarie Perron of the Perelman School of Medicine says that the appearance and progression of skin ulcers and tissue loss on xylazine users is different than with other intravenous drugs.
FULL STORY →
It’s time to end the Medicare-Medicaid merry-go-round
In an opinion essay, Rachel M. Werner of the Leonard Davis Institute, Wharton School, and Perelman School of Medicine says that Medicare and Medicaid fail to integrate coverage and coordinate care across their two plans.
FULL STORY →
The quest for treatments to keep weight off after Ozempic
Researchers at Penn are conducting a co-authored study of the brains, fat and muscle cells, and eating patterns of people trying to maintain new body sizes.
FULL STORY →
Inside Penn’s transfer center
Penn Medicine’s transfer command center gets patients from affiliated hospitals and hospitals outside Philadelphia to specialized care that can save lives, with comments from CEO Kevin Mahoney.
FULL STORY →
Operating rooms are major sources of greenhouse gasses. Penn is eliminating a form of anesthesia that hangs in the air for more than a decade after use
Penn Medicine is phasing out the anesthesia desflurane at four of its six hospitals to eliminate harmful greenhouse gases, with remarks from Greg Evans.
FULL STORY →